TERN News and Press, Terns Pharmaceuticals Inc. From 11/04/25

A look at the top 10 most actives in the United States MSP Recovery Inc. (MSPR) rose 136.6% to $0.5205 on volume of 871,666,816 shares EZGO Technologies Ltd. (EZGO) rose 29.1% to $0.1752 on volume of 233,724,963 shares Kenvue Inc. (KVUE) rose 12.3% to $16.14 on volume of 203,525,996 shares ...

2025-11-03 16:37:31 ET Evan Seigerman from BMO Capital issued a price target of $22.00 for TERN on 2025-11-03 21:01:09. The adjusted price target was set to $22.00. At the time of the announcement, TERN was trading at $14.03. The overall price target consensus is at $15....

A look at the top 10 most actives in the United States MSP Recovery Inc. (MSPR) rose 198.4% to $0.6564 on volume of 840,159,216 shares EZGO Technologies Ltd. (EZGO) rose 32.2% to $0.1794 on volume of 227,136,454 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 1.8% to $3.2617 ...

2025-11-03 12:15:11 ET William Blair analyst issues OUTPERFORM recommendation for TERN on November 3, 2025 03:27PM ET. The previous analyst recommendation was Market Perform. TERN was trading at $15.51 at issue of the analyst recommendation. The overall analyst consensus...

Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population Encouraging safety and tolerability profile at all doses evaluated Company to host investor update call on December 8 th at 4:30pm ET FOSTER CITY, Cali...

2025-10-22 16:11:52 ET The last time I wrote about Terns Pharmaceuticals ( TERN ), it was with respect to a Seeking Alpha article entitled " Terns Pharmaceuticals: Obesity Advancement Continues With Other Q1 2025 Program Catalyst ". With respect to this article, I noted ...

2025-10-21 17:47:06 ET More on Terns Pharmaceuticals Terns Pharmaceuticals: Valued As If It Can't Win Terns Pharmaceuticals, Inc. (TERN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript Terns Pharmaceuticals, Inc. - TERN-701 Investor Edu...

Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three participants during post-treatment follow-up period, two of which were deemed drug related ...

2025-10-14 18:08:06 ET from Truist Financial issued a price target of $20.00 for TERN on 2025-10-14 20:06:49. The adjusted price target was set to $20.00. At the time of the announcement, TERN was trading at $8.08. The overall price target consensus is at $15.00 with hig...

2025-10-03 13:47:03 ET Thesis Structure Therapeutics Inc. (GPCR) is a clinical-stage biotechnology company focused on obesity linked drug developments. It is a GLP-1 oral pure play trying to access one of today’s largest and fastest-growing segments in the pharma industry...